Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
Fudan University
Fudan University
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Stanford University
Stanford University
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Stanford University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Medical College of Wisconsin
Trans Tasman Radiation Oncology Group
Northwell Health
Trans Tasman Radiation Oncology Group
Masonic Cancer Center, University of Minnesota
Trans Tasman Radiation Oncology Group
Baylor College of Medicine
Baylor College of Medicine
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
Trans Tasman Radiation Oncology Group
Dana-Farber Cancer Institute